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This issue of Frontiers in ImmunologicTolerance explores barriers to tolerance from a vari-
ety of views of cells, molecules, and processes of the immune system. Our laboratory
has spent over a decade focused on the migration of the cells of the immune system, and
dissecting the signals that determine how and where effector and suppressive regulatory
T cells trafﬁc from one site to another in order to reject or protect allografts. These studies
have led us to a greater appreciation of the anatomic structure of the immune system,
and the realization that the path taken by lymphocytes during the course of the immune
response to implanted organs determines the ﬁnal outcome. In particular, the structures,
microanatomic domains, and the cells and molecules that lymphocytes encounter during
their transit through blood, tissues, lymphatics, and secondary lymphoid organs are pow-
erful determinants for whether tolerance is achieved. Thus, the understanding of complex
cellular and molecular processes of tolerance will not come from “96-well plate immunol-
ogy,” but from an integrated understanding of the temporal and spatial changes that occur
during the response to the allograft.The study of the precise positioning and movement of
cells in lymphoid organs has been difﬁcult since it is hard to visualize cells within their three-
dimensional setting; instead techniques have tended to be dominated by two-dimensional
renderings, although advanced confocal and two-photon systems are changing this view. It
is difﬁcult to precisely modify key molecules and events in lymphoid organs, so that exist-
ing knockouts, transgenics, inhibitors, and activators have global and pleiotropic effects,
rather than precise anatomically restricted inﬂuences. Lastly, there are no well-deﬁned
postal codes or tracking systems for leukocytes, so that while we can usually track cells
from point A to point B, it is exponentially more difﬁcult or even impossible to track them to
point C and beyond. We believe this represents one of the fundamental barriers to under-
standing the immune system and devising therapeutic approaches that take into account
anatomy and structure as major controlling principles of tolerance.
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INTRODUCTION
This issue of Frontiers in Immunologic Tolerance explores barri-
ers to tolerance from a variety of views of cells, molecules, and
Abbreviations:Aire, autoimmune regulator;APC, antigen-presenting cell; DC,den-
dritic cell; ER-TR7, Erasmus University Rotterdam- thymic reticulum antibody 7;
FDC, follicular dendritic cell; FRC, ﬁbroblastic reticular cell; FTreg, follicular regu-
latory T cells; GITR, glucocorticoid-induced tumor necrosis factor receptor; HEV,
high endothelial venules; HSPC, hematopoietic stem/progenitor cells; HVEM, her-
pes simplex virus (HSV) glycoprotein D for HSV entry mediator; imDC, immature
myeloid DC; LEC, lymphatic endothelial cells; LN, lymph node; LT, lymphotoxin;
LTβR, Lymphotoxin β receptor; LTi, lymphoid tissue inducer; LTo, lymphoid tis-
sue organizer; LYVE-1, lymphatic vessel endothelial hyaluronan receptor 1; nTreg,
natural Treg; PALS, periarteiolar lymphoid sheath; pDC, plasmacytoid DC; PD-
L1, programmed death ligand 1; PNAd, peripheral lymph node addressin; PP,
Peyer’s patches; PTA, peripheral tissue-restricted antigen; SCS, subcapsular sinus;
SIV, Simian immunodeﬁciency virus; SLO, secondary lymphoid organs; TCR, T cell
receptor; TFH, follicular helper T cells; TGFβR, TGFβ receptor; TLO, tertiary lym-
phoid organs; TNF, tumor necrosis factor; Treg, regulatory T cells; TSLP, thymic
stromal lymphopoietin; VEGF, vascular endothelial growth factor.
processes of the immune system. Our laboratory has spent over
a decade focused on the migration of the cells of the immune
system, and dissecting the signals that determine how and where
effector and suppressive regulatory T cells trafﬁc from one site
to another in order to reject or protect allografts. These studies
have led us to a greater appreciation of the anatomic structure
of the immune system, and the realization that the path taken
by lymphocytes during the course of the immune response to
implanted organs determines the ﬁnal outcome. In particular, the
structures, microanatomic domains, and the cells and molecules
that lymphocytes encounter during their transit through blood,
tissues, lymphatics, and secondary lymphoid organs (SLOs) are
powerful determinants for whether tolerance is achieved. Thus,
the understanding of complex cellular and molecular processes of
tolerance will not come from “96-well plate immunology,” but
from an integrated understanding of the temporal and spatial
changes that occur during the response to the allograft. The study
of the precise positioning and movement of cells in lymphoid
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organs has been difﬁcult since it is hard to visualize cells within
their three-dimensional setting; instead techniques have tended to
be dominated by two-dimensional renderings, although advanced
confocal and two-photon systems are changing this view. It is dif-
ﬁcult to precisely modify key molecules and events in lymphoid
organs, so that existing knockouts, transgenics, inhibitors, and
activators have global and pleiotropic effects, rather than precise
anatomically restricted inﬂuences. Lastly, there are nowell-deﬁned
postal codes or tracking systems for leukocytes, so that while we
can usually track cells from point A to point B, it is exponentially
more difﬁcult or even impossible to track them to point C and
beyond. We believe this represents one of the fundamental barri-
ers to understanding the immune system and devising therapeutic
approaches that take into account anatomy and structure as major
controlling principles of tolerance.
SECONDARY LYMPHOID ORGANS
STRUCTURE
It is ﬁrst important to understand the structure, development, and
regulatory mechanisms of lymphoid organs to provide the basis
for understanding on how these control immunity and tolerance.
The lymph node (LN) is an encapsulated, highly organized SLO
(Figures 1C,D). The separate regions are the cortex, the para-
cortex, and the medulla. The cortex is the most outer layer and
contains B cells, macrophages, and follicular dendritic cells (FDC)
arranged in primary follicles. The paracortex is the next layer,
which contains T cells and dendritic cells (DC). Fibroblastic retic-
ular cells (FRC) supportT cell andDC interactions in this area. The
most inner layer, the medulla, consists of lymphatic tissues called
medullary cords, which are separated by the lymph ﬁlled spaces
of the medullary sinuses. The LN vasculature consists of high
endothelial venules (HEV), the characteristic structure through
which T cells and B cells enter into LN from the blood, and
lymphatic vessels lined by lymphatic endothelial cells (LEC).
The spleen is surrounded by a capsule that extends many pro-
jections into the interior to form a compartmentalized structure
(Figures 1A,B). There are two compartments, the red pulp and
the white pulp, and a diffuse marginal zone that separates them.
The red pulp is a network of sinusoids populated by macrophages
and red blood cells. The splenic white pulp forms a periarterio-
lar lymphoid sheath (PALS) populated mainly by T cells. B cell
follicles, supported by FDC as in the LN, are next to the PALS.
FIGURE 1 | Structure of SLO. Fluorescent immunohistochemistry (left)
and cartoons (right) illustrate the structure and cellular content of
spleen (A,B) and LN (C,D). (A)The outer capsule of the spleen surrounds
the red pulp, with the sinuses and white pulp embedded within. ER-TR7
ﬁbers form a network supporting the red pulp, and FRC line the borders
between the red and white pulp. A central arteriole empties into the white
pulp. (B) In the white pulp, T cells populate the PALS leading into the B cell
follicles. DC line the marginal sinus, enclosed by the marginal zone. (C) In
the LN, the efferent lymphatics empty into the medullary sinus and travel
through the medullary cords. Lymphocytes enter through the HEV, which
seed the LN. (D) B cells, FDC, and macrophages lay in the cortex. The
paracortex containsT cells and DC. Antigen presentation andT cell priming
occur at the cortical ridge areas between B andT cell zones supported by
FRC.
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The marginal sinus and its associated layer of FRC and MOMA-1
staining metallophilic macrophages deﬁne the outer boundary of
the white pulp.
LTi AND LTo CELLS – DEFINITION AND FUNCTION
Lymph nodes develop during embryogenesis or in the ﬁrst few
weeks after birth through recruitment and interaction of lym-
phoid tissue inducer (LTi) cells and lymphoid tissue organizer
(LTo) cells. The central role of the LTi cells in LN development is
the expression and presentation of lymphotoxin alpha and beta
(LTα1β2) to the LTβ receptor (LTβR) on LTo, and this interaction
leads to organized lymphoid structures. The importance of this
signal is demonstrated in mice deﬁcient in LTβR or LTα, which
lack LN and Peyer’s patches (PP; De Togni et al., 1994; Futterer
et al., 1998). Although the early differentiation pathway of LTi
cells from multipotent hematopoietic progenitor cells remains to
be characterized, studies suggest that the early speciﬁcation to the
LTi lineage takes place in lineage marker-negative (Lin−) popu-
lations, and α4β7 integrin, IL-7Rα+, and CD4+CD3− are useful
markers to deﬁne LTi (Mebius et al., 1996; Yoshida et al., 1999;
Honda et al., 2001). A recent study shows that transcription fac-
tor Runx/Cbfb2 complexes are required for LTi cell differentiation
(Tachibana et al., 2011). LTo cells, also called mesenchymal orga-
nizer cells or stromal organizer cell, express LTβR. LTo can be
derived from the antimesenteric side of the intestine during devel-
opment or from a hematopoietic cell lineage (Adachi et al., 1998;
Nishikawa et al., 2000). The LTi–LTo interaction activates a sig-
naling cascade resulting in the expression of adhesion molecules
such asVCAM-1, intercellular cell adhesionmolecule-1 (ICAM-1),
and mucosal addressin cell adhesion molecule-1 and homeostatic
chemokines such as CXCL13, CCL19, and CCL21 (van de Pavert
and Mebius, 2010). CXCL13, the B zone chemokine, recruits cir-
culating B cells to what becomes the B cell area; and the T zone
chemokines, CCL19 and CCL21, attract T and DC to shape the
T cell area (Cupedo and Mebius, 2005; Scandella et al., 2008).
The human equivalent of murine LTi cells has been identiﬁed but
has not been as well characterized as in mice. LTi cells in adult
human are identiﬁed as IL-22 expressing NK type cells (Cupedo
et al., 2009). The major phenotypic difference between mouse and
human LTi cells is that mouse LTi cells are either CD4+ or CD4−,
while human LTi cells are CD4− or CD4low (Kim et al., 2009).
In addition to organizing lymphoid structure during develop-
ment, LTi cells are present in adult lymphoid tissues. Even after the
maturation of SLO, a continuous interplay between lymphocytes
and stromal cells is likely to be required for the maintenance of tis-
sue architecture and the characteristics of adult stromal cells.Adult
LTi cells express OX40L and CD30L,which are critical for memory
CD4 T cell generation (Kim et al., 2005). OX40 and CD30 deﬁ-
cientmice have impairedCD4T cell-dependentmemory antibody
responses in the spleen and gut (Lane et al., 2008; Tsuji et al., 2008).
LTo give rise to various stromal cell subsets such as FDC and FRC
that are present in lymphoid organs.However, it remains unknown
how many different mesenchymal stromal cell types exist in SLO.
The relationship between embryonic LTo cells and different types
of stromal cells in adult SLO, and the postnatal fate of LTo cells are
also unclear. It is possible that LTo-like cells persist in the adult and
play a role in the maintenance of SLO. Katakai et al. (2008) found
a layer of unique reticular cells underneath the subcapsular sinus
(SCS) lining of adult LNs. These specialized mesenchymal cells,
marginal reticular cells (MRS), sharemany characteristicswith LTo
cells and are observed in mucosal SLO such as PP, nasal-associated
lymphoid tissues, and isolated lymphoid follicles of adult mice
(Katakai et al., 2008).
Splenic LTi-like cells contribute the development of SLO and
also to host defense, by producing IL-17 and IL-22 in response
to pathogen or IL-23 stimulation (Takatori et al., 2009). Phe-
notypically, splenic LTi-like cells in adult mice are similar to
LN. They are CD4+CD3−NK1.1−CD11b−Gr-1−CD11c−B220−,
express RORγt, aryl hydrocarbon receptor, IL-23R and CCR6, and
are located mainly in the white pulp, particularly at the junction
of T- and B-zones in the follicle. Formation of splenic white pulp
does not require LTi cells, but thematuration of the tissue structure
depends on LTα1β2 produced by lymphocytes and LTβR signal-
ing (Fu and Chaplin, 1999), so that LTα, LTβ, or LTβR deﬁcient
mice display disrupted splenic architecture (De Togni et al., 1994).
Thus, despite some similarities, the developmental program and
molecular requirements of each SLO are clearly different.
LYMPHOTOXIN SYSTEM
LT is a tumor necrosis factor (TNF)-related cytokine required
for the development and organization of SLO (Cyster, 2003). Its
ligands and receptors are summarized in Figure 2. There are
four closely related ligands: LTα; LTβ; TNF; and “homologous
to LT, inducible expression, competes with herpes simplex virus
(HSV) glycoprotein D for HSV entry mediator (HVEM), a recep-
tor expressed on T lymphocytes” (LIGHT or TNFSF14). There are
four cognate receptors: TNFR1; TNFR2; LTβ; and HVEM. LTα
and LTβ form three different ligands, a secreted homotrimer LTα3
and two membrane-bound heterotrimers LTα1β2 (predominant
form) and LTα2β1. The ligand–receptor binding patterns over-
lap within the family. LTα3 binds TNFR1 and TNFR2; LTα1β2
FIGURE 2 |The lymphotoxin receptors and their ligands.The
interactions of TNF cytokines with their cognate receptors are shown by
arrows. Both LTα1/β2 and LIGHT bind to LTβR. HVEM binds to membrane
or soluble LIGHT, soluble LTα3. Soluble LTα3 binds to TNFRI andTNFR II.
Dashed line refers to weak interactions.
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signals through LTβR; LTα2β1 binds TNFR1 and TNFR2; and
LIGHT interacts with LTβR and HVEM. LTα3 may also bind
HVEM (Schneider et al., 2004). As mentioned above, LT express-
ing LTi cells interact with the corresponding LTβR on the LTo cells
during development. LTβR signaling is also required for maintain-
ing the structure and regulating immune responses in adult mice
(McCarthy et al., 2006).
The development of the spleen is independent of LT, however,
the microarchitecture of the splenic white pulp requires LTβR sig-
naling for its development and maintenance in the adult mice.
Treatment with LTβRIg, which blocks LT signaling, dissolves dis-
crete B cell follicles, alters the marginal zone, prevents germinal
center formation in the spleen, and impairs antibody production
in response to immunization (Mackay et al., 1997).
SECONDARY LYMPHOID ORGANS AND TOLERANCE
Stromal cell function and tolerance
The appropriate structure of the SLO is integral in immune fate
decisions, as following SLO entry naïve lymphocytes must decide
to remain naïve, or become activated, anergic, or deleted. The
presence (or absence) of antigen, co-stimulation, cell interactions,
and/or chemokines/cytokines are all instructive in these decisions.
Stromal cells construct intricate scaffolding within the SLO and
provide architectural support. In addition to deﬁning structure,
these cells also contribute to lymphocyte trafﬁcking, antigen pre-
sentation and cellular interactions (Mueller and Germain, 2009;
Luther et al., 2011). FRC produce and secrete a ﬁbrous antigen
detected by the Erasmus University Rotterdam-thymic reticulum
antibody 7 (ER-TR7; Steele et al., 2009) that forms a meshwork
throughout the SLO (Van Vliet et al., 1986; Mueller and Germain,
2009). As elegantly demonstrated by Katakai et al. (2004b), the
assembly of the ER-TR7 protein into thismeshwork frame involves
both FRC and lymphocyte collaboration and changes in response
to antigen challenge, suggesting a structural plasticity thatmolds to
the immune challenge at hand. To generate a fully formed mesh-
work, signaling through TNFR and LTβR via the inﬂammatory
cytokines TNFα, LTα, and LTβ is required.
In the LN, lymphocytes leave the blood and enter via the
HEV before ﬂowing to the cortical ridge and cortical sinuses
(Grigorova et al., 2010). As the HEV are the entry points for lym-
phocytes, the signals they present may be important factors in the
genesis and shape of the immune response. Following inﬂamma-
tory challenge, HEV express peripheral node addressin (PNAd),
CCL21, ICAM-1, and CXCL9, attracting CD62L+, CCR7+, LFA-
1+, and/or CXCR3+ T cells (Springer, 1994; Guarda et al., 2007).
To attract B cells, HEV express CXCL13 resulting in cell arrest and
LN entry (Kanemitsu et al., 2005). Even at this early phase of lym-
phocyte:LN interaction, lymphocytes encounter fate determining
signals at the HEV. Activated T cells and antigen-presenting DC
home to HEV following infection (Bajenoff et al., 2003), and we
have shown both antigen and Treg seeding along HEV in tolerant
mice following transplantation (Ochando et al., 2006). These ﬁnd-
ings suggest that these responding cells and/or antigen-presenting
cells (APC) shape the migratory path of naïve lymphocytes into
or through the LN and the subsequent immune response.
Following LN entry via HEV, or splenic entry via central arte-
rioles in the marginal zone (Steiniger et al., 2001), lymphocytes
encounter the FRC network, which dictates their path through the
SLO (Mueller and Germain, 2009). The FRC are layered on top
of and entwining the ER-TR7 scaffolding, forming a conduit sys-
tem that transports molecules sampled from the lymph which
has entered into the capsule and through the cortex (Katakai
et al., 2004b). Lymphocytes (Gretz et al., 1997), soluble factors
(Gretz et al., 1997), low molecular mass molecules (Gretz et al.,
2000), and antigen (Pape et al., 2007) pass through these con-
duits, traveling through the reticular network from the SCS to
the HEV. Conduit-transported antigen travels to varying loca-
tions within the LN. If antigen is transported to follicles, B cells
take it up and become activated (Pape et al., 2007). If the anti-
gen is acquired from the lymph, it can be presented by lymphatic
vessel endothelial hyaluronan receptor 1 (LYVE-1)+, conduit-
associated, DC (Gretz et al., 1997). These resident DC are asso-
ciated with reticular ﬁbers within the LN (Sixt et al., 2005), and
can take up antigen within minutes following exposure (Itano
and Jenkins, 2003). Interestingly, immature DC (such as resi-
dent DC) adhere much more readily than mature DC (such as
recently migrated inﬂammatory DC) to the extracellular matrix
(Sixt et al., 2005), and may be of exceptional signiﬁcance in
terms of tolerance, as immature DC would fail to provide the
requisite co-stimulation signals needed for T cell activation and
may be tolerogenic (Itano and Jenkins, 2003). Hence, if poten-
tially graft-reactive T cells encounter these immature as opposed
to mature DC, the T cells may become anergic rather than
primed.
Fibroblastic reticular cells not only form the physical struc-
ture of conduits to allow the ﬂow of antigen and cells in the LN
(Link et al., 2011) and spleen (Nolte et al., 2003), they also affect
chemotaxis of lymphocytes andDCby producing chemokines and
expressing adhesion markers. Stromal cells lining the HEV express
CCL19 (Forster et al., 2008) andCCL21 (Luther et al., 2000; Forster
et al., 2008), which are indispensable for attracting T cells and DC
via surface CCR7 engagement, both to the LN and then to T cell
area (Forster et al., 2008). Further, stromal cells express the adhe-
sion molecules ICAM-1 (Boscacci et al., 2010), ICAM-2 (Boscacci
et al., 2010), VCAM-1 (Katakai et al., 2004a; Boscacci et al., 2010),
and sialic acid (Kraal et al., 1994); adhesion molecules that direct
lymphocytes expressing LFA-1 or α4β1 (Lo et al., 2003) to enter
the HEV in the LN (Boscacci et al., 2010) or white pulp in the
spleen (Kraal et al., 1994; Lo et al., 2003), and home to distinct
microdomains.
The chemokines CXCL12 (Wright et al., 2002; Katakai et al.,
2004a) and CX3CL1 (Katakai et al., 2004a) further direct lympho-
cyte homing to and within SLO (Boscacci et al., 2010). CXCL12,
displayed on HEV (Okada et al., 2002), interacts with CXCR4 on
central memory CD8+ T cells (Scimone et al., 2004) and B cells
(Okada et al., 2002), attracting these cells to the LN independent
of CCR7 expression (Scimone et al., 2004). CXCL12 expression
may be of special importance in terms of transplant tolerance as
it results in plasmacytoid DC (pDC) LN recruitment (Vanbervliet
et al., 2003), and pDC presentation of donor antigen is integral to
inducing tolerance to vascularized grafts (Ochando et al., 2006).
Further, stromal cells guide activated follicular B cells to T cell
zones and sites of T cell help following their upregulation of CCR7
(Reif et al., 2002).
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Fibroblastic reticular cells may also deliver inhibitory or nega-
tive signals to lymphocytes, preventing their homing to and within
SLO. FRC produce CCL2 (Katakai et al., 2004b), resulting in
decreased lymphocyte homing and effector function by preventing
activation of LFA-1, inhibiting ICAM-1 attachment, and subse-
quent adhesion steps and travel to SLO (Flaishon et al., 2008). FRC
also express class IMHCand the inhibitorymolecule programmed
cell death ligand 1 (PD-L1), and are thus capable of delivering
signals to lymphocytes moving across their surfaces, inﬂuencing
tolerance versus immune activation by tuning the responsiveness
or activation state of the lymphocytes (Mueller and Ernst, 2007).
Thus, FRC not only help attract lymphocytes to the LN and to
speciﬁc areas within the LN, they also help dictate the interactions
of the cells inside the LN. Interactions in the LN can also dictate
where the activated lymphocytes travel following LNactivation. By
expressing retinoic acid in the LN, stromal cells (Hammerschmidt
et al., 2008), and resident DC (Iwata et al., 2004) induce α4β7 and
CCR9 upregulation of activated T cells, resulting in their travel to
the gut.
Fibroblastic reticular cells provide both cues and scaffolding,
dictating the movements, and interactions of the diverse cell pop-
ulations residing and migrating through the SLO. These observa-
tions suggest a model in which a transplant recipient encounters
donor antigen, and as the recipient responds to these antigens
lymphoid organ structure is remodeled. SLO structure affects
both primary and subsequent immune responses to alloantigens,
altering where antigen is presented, which cell types encounter
antigen, the activation signals detected by these cell types, and
the interactions of the various cell populations. Further levels of
complexity include that SLO structure is inﬂuenced by previous
inﬂammatory and antigen challenges, so the structure within the
SLO of the transplant recipient may be as unique as a ﬁngerprint.
Hence, detection of these distinctive structural and environmen-
tal pressures may provide novel and unique targets for designing
therapeutic protocols.
Spleen
The spleen’s role in graft rejection is different betweenmodels such
as vascularized or non-vascularized organ transplantationmodels.
In some vascularizedmodels, it contributes to graft rejection; how-
ever, in non-vascularized transplantation models, LN but not the
spleen are essential for the rejection of skin allografts. Rather, the
spleen appears to enhance graft prolongation (Souther et al., 1974;
Streilein and Wiesner, 1977; Coons and Goldberg, 1978; Lakkis
et al., 2000). The rejection of skin allografts depends on the pres-
ence of LN, whereas the rejection of vascularized heart allografts
occurs in the presence of either the spleen or LN (Lakkis et al.,
2000). On the contrary, Chosa et al. (2007) showed that the spleen
plays an important role in maintaining tolerance after removal
of the vascularized heart graft. The APC migration route might
explain the difference between models. In vascularized transplan-
tation models, passenger leukocytes, including DC, are thought to
migrate from the vascularized graft into the recipient spleen,where
they activate T cells and cause rejection (Larsen et al., 1990a,b;
Saiki et al., 2001). In the case of tolerance maintenance, naïve DC
migrate to a tolerant graft and become regulatory or immature
DC, these DC may then migrate to the spleen where they generate
Treg (Chosa et al., 2007). CD4+ T cells from spleen of unrespon-
sive cardiac allograft transplant recipients showed increased IL-10
and decreased IL-4 and IFNγ (DePaz et al., 2003).
In non-vascularized grafts, DC migrate from the graft to the
regional draining LN. Activated DC are trapped in the LN where
they generate effector T cells from naïve T cells. Regulatory or
immature DC may pass through the LN, reach the spleen, and
generate Treg. Several studies indicate that the expression pattern
of chemokines and cytokine receptors between LN and spleen is
different, explaining the different roles in transplant models (Tang
and Cyster, 1999; Alferink et al., 2003).
Suppression and regulatory mechanisms of the spleen are
shown in several studies. A subset of splenic red pulp F4/80hiMac-
1low macrophages, whose differentiation is regulated by CSF-1,
regulates CD4+ T cell responses using TGFβ and IL-10 and induc-
ing differentiation of Foxp3+ Treg (Kurotaki et al., 2011). In a
vascularized transplant model, Li et al. (2010) showed that CD8+
Treg and pDC in the allograft and spleen induce tolerance. In
mice, a rare cell type located in splenic red pulp with phenotypic
attributes of DC (CD11c, CD8, CD80/86, MHCII) are uniquely
competent to mediate T cell suppression via indoleamine oxi-
dase after in vivo treatment with TLR9 ligands (Mellor et al.,
2005; Johnson et al., 2010). NK cells have been shown to con-
tribute to both graft rejection and tolerance both in cardiac and
skin transplant models (Heidecke et al., 1985; Rabinovich et al.,
2000; Beilke et al., 2005; Kroemer et al., 2008; Zecher et al., 2010).
Thus, activated, regulatory, or immature DC and NK cells trapped
in the spleen interact with other innate and adaptive immune
cells, generate effector T cells and Treg, which contribute either to
rejection or acceptance depending on the model (Murphy et al.,
2011). The possibility that the spleen has the two functions of graft
rejection and graft prolongation has been demonstrated in spleen
transplantation models (Dor et al., 2003).
Lymph node
In addition to dictating movement of lymphocytes within the LN
by supplying both structure and directional cues, stromal cells
may also dictate lymphocyte survival. Stromal cells affect T cell
viability, and correct positioning within the LN is integral to T cell
survival (Table 1). Highlighting this importance is the effect of
HIV pathogenesis on CD4+ T cell survival. Following HIV infec-
tion, the LN T cell zones become areas of signiﬁcant pathology as
viral replication occurs almost exclusively in these areas (Schacker
et al., 2001). Innate immune cells attack these areas in attempts
at viral eradication, resulting in scarring, and collagen deposition
within LN niches (Estes et al., 2008), along with structural disso-
lution within the LN (Biberfeld et al., 1985). This scaring inhibits
T cell access to FRC-produced IL-7, resulting in the depletion of T
cells via apoptosis (Zeng et al., 2011). As T cells are depleted, the
source of LTβ production is decreased, leading to further disrup-
tion of the FRC network (Zeng et al., 2011). The interdependence
between FRC and T cells for the maintenance of LN structure
demonstrates the balance among activation, ignorance, or toler-
ance that is dependent upon the microdomains within the LN
structure.
Stromal cells also participate in peripheral tolerance by express-
ing autoimmune regulator gene (Aire). Aire expression is most
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Table 1 | Stromal cells in SLO.
Name Location Phenotype Function
Follicular dendritic cell
(FDC)
Cortex, B cell primary
follicle (LN and spleen)
CD45−CD35+
FDC-M1+
Regulate B cell homeostasis, migration, and survival (Gunn et al., 1998a;
Hase et al., 2004; Munoz-Fernandez et al., 2006)
Express complement and Fc receptors and are able to trap immune
complexes to present B cells (Aguzzi and Krautler, 2010)
Activate B cells by presenting exogenous antigen (El Shikh et al., 2010)
Express CXCL13, attracting naïve B cells expressing CXCR5 (Aguzzi and
Krautler, 2010)
Fibroblastic reticular
cell (FRC)
Paracortex, T cell area
(LN and spleen)
CD45− Support B cell, T cell, and DC interactions (Katakai et al., 2004a; Bajenoff
et al., 2006)gp38(podoplanin)+
CD31−
ER-TR7+
VCAM-1high
CD44high
Directly induce tolerance of responding naïve CD8T cells (Lee et al., 2007)
Express peripheral tissue antigens (PTAs)
Present antigens to stimulate naïve T cells (Fletcher et al., 2010b)
Secrete collagen and other extracellular matrix (Fletcher et al., 2010a)
Create a conduit system of ﬁne microchannels that conduct small lymph-
borne antigens and inﬂammatory mediators deep into the LN paracortex
B cells use the FRC network to reach the follicles
Express CCL19, CCL21, and SDF1 (CXCL12; Luther et al., 2000)
Express IL-7 which promotes survival of naïve T cells (Link et al., 2007)
Lymphatic endothelial
cell (LEC)
LN CD45− Directly induce tolerance of responding naïve CD8T cell (Cohen et al., 2010)
Regulate T cell entry to and exit from LNsgp38+CD31+
VCAM-1low
CD44low
Blood endothelial cell
(BEC)
LN and spleen CD45−gp38− Express PTAs (Cohen et al., 2010; Fletcher et al., 2010b)
Regulate T cell entry to and exit from LNsCD31+
VCAM-1low
CD44low
Double negative (DN) CD45−gp38−CD31− Express PTAs (Cohen et al., 2010; Fletcher et al., 2010b)
commonly associated with thymic expression of tissue-speciﬁc
antigens; antigens that represent autologous proteins not typically
present within the thymus. By presenting these antigens dur-
ing thymic selection, potentially autoimmune T cells are deleted
(Anderson et al., 2002). More recently, a role for Aire in periph-
eral tolerance has been demonstrated (Metzger and Anderson,
2011). Under steady-state conditions, tissue resident DC in the
periphery pick up peripheral tissue-restricted antigen (PTA), and
migrate to the LN (Waithman et al., 2007). There, Aire-expressing
gp38+CD31+ lymphatic endothelial (Cohen et al., 2010) and
gp38+CD31− stromal cells (Gardner et al., 2008) express these
antigens. These stromal cells express a variety of antigen process-
ing and presentation genes, including MHC II, having phenotypic
similarities to DC (Gardner et al., 2008). Hence, it is possible that
allograft antigens, entering the LN either via lymphatic conduits
or tissue DC,may be picked up by endothelial and/or stromal cells
and presented to potentially graft-reactive lymphocytes, resulting
in tolerance instead of activation. Indeed, theAire-expressing stro-
mal cells are preferentially located along boundaries of T and B cell
interactionswithin the LN (Gardner et al., 2008), and are sufﬁcient
to drive both proliferation and deletion of self-reactive CD8+ T
cells (Lee et al., 2007). Signiﬁcantly, these stromal cells also express
PD-L1, suggestive of a potential mechanism for peripheral cell
deletion (Gardner et al., 2008). This CD8+ T cell deletion strategy
is mirrored in chronic viral infection; LCMV upregulates PD-L1
in FRC, deleting virus-speciﬁc potential effector cells and allowing
for viral persistence (Mueller et al., 2007).
Different subsets of stromal cells express Aire and PTA to
varying degrees (Cohen et al., 2010). FRC express PTA under
steady-state conditions, and down-modulate their antigen expres-
sion following an inﬂammatory stimulus (Fletcher et al., 2010a).
In contrast, other LN stromal cell subsets increase their PTA
expression in response to bystander inﬂammation (Fletcher et al.,
2010a). Thus, speciﬁc subsets of stromal cells may be responsible
for speciﬁc antigen tolerance. These ﬁndings may be exploited in
transplant tolerance, as presentation of donor antigen in a non-
inﬂammatory environment may engage several different tolerance
mechanisms. Donor antigen could potentially be targeted to stro-
mal cells for presentation, or therapeutic interventionsmay be able
to exploit naturally occurring peripheral tolerance mechanisms.
BLOOD VASCULAR ENDOTHELIUM
Dendritic cell and lymphocytes enter the LN through HEV and
afferent lymphatics (vonAndrian and Mempel, 2003). During this
process, lymphatics and HEV not only play a role as a route for
cell trafﬁcking but also interact with the migrating immune cells
to inﬂuence their immunologic properties and thereby immune
responses. HEV are specialized postcapillary venules found in LN,
where the lymphocytes circulating in the blood enter the LN by
diapedesis (Girard and Springer, 1995). In order to facilitate the
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migration of lymphocytes, endothelial cells inHEV secrete CCL21,
the CCR7 ligand, and express adhesion molecules such as PNAd
(ligand for CD62L) and ICAM-1 (ligand for LFA-1; Campbell
et al., 1998; Gunn et al., 1998b; Forster et al., 2008). An addi-
tional chemokine CX3CL1, expressed on inﬂamed endothelial
cells, interacts with its receptor CX3CR1 on activated cytotoxic
lymphocytes, functioning as a cell adhesion molecule (Umehara
et al., 2004). Another CCR7 ligand, CCL19, is produced by FRC
in the T cell area and can be transported to the luminal surface of
HEV to mediate T cell recruitment (Baekkevold et al., 2001; Link
et al., 2007). CCR7 signaling is reported to induce cell cycle arrest
in T cell receptor (TCR)-stimulated T cells and inhibit T cell pro-
liferation (Ziegler et al., 2007). CCR7 signaling acts differently on
DC. CCL19 and CCL21 induce DC to become mature; produce
proinﬂammatory cytokines such as IL-1β, IL-12, and TNFα; and
drive Th1 responses (Marsland et al., 2005). Thus, by engaging
CCR7 and directing the migration of T cells and DC from blood
into the LN, HEV induce signiﬁcant changes in the maturation,
differentiation, and responses of the migrating leukocytes.
Whether HEV enhance immune regulatory capacity of Treg is
not certain. In an islet allograft model, adoptively transferred Treg
that enter LN through HEV do not acquire an activated phenotype
to suppress the alloimmune response (Zhang et al., 2009). On the
other hand, activated endothelial cells from other sources such as
thoracic aorta and lung induce and activate Treg using the PD-
1/PD-L1 interaction and IL-10 (Krupnick et al., 2005; Bedke et al.,
2010). Under inﬂammatory conditions, human endothelial cells
amplify Treg in a contact-ICAM-1-dependent mechanism (Taﬂin
et al., 2011). Under tolerogenic conditions, alloantigen-presenting
pDC also migrate through HEV when homing to LN, to mediate
Treg development and tolerance to vascularized cardiac allografts
(Ochando et al., 2006).
LYMPHATIC ENDOTHELIUM
Lymphatics are lined with LEC expressing LYVE-1. Lymphatics
are found throughout the LN and have different functions and
phenotypes in different regions. DC and T cells in peripheral tis-
sues enter LN through afferent lymphatics, which typically end
in the SCS, a hollow space below the ﬁbrous capsule of the LN
(Randolph et al., 2005). Thereafter, DC and T cells use different
routes for entry into the LN parenchyma. By injecting cells directly
into afferent lymph vessels, Braun et al. (2011) showed that DC
transmigrate through the ﬂoor of the SCS on the afferent side in
CCR7-dependent fashion to enter the LN parenchyma. On the
other hand, T cells enter the LN parenchyma mainly from periph-
eral medullary sinuses and this is not CCR7-dependent. However,
CCR7 signals are absolutely required for the directional migration
of both DC and T cells into the T cell zone. Interestingly, when DC
are injected before T cells, T cells are able to transmigrate through
the SCS ﬂoor. This suggests that DC transmigrating through the
SCS induce changes in SCS morphology. In the steady state, Treg
also enter the LN via afferent lymphatics, which is increased in
inﬂammatory conditions (Tomura et al., 2010).
When leaving the LN, lymphocytes in the parenchyma enter
medullary networks of lymphatic sinuses and from there the effer-
ent lymphatics (von Andrian and Mempel, 2003). Lymphatics
associated with the egress of lymphocytes are also found adjacent
to HEV and B cell follicles in cortex (Sinha et al., 2009; Grigorova
et al., 2010). These cortical sinuses extend to medullary sinuses.
Emigration of lymphocytes into the efferent lymphatics for egress
from the LN requires sphingosine-1-phosphate (S1P) interaction
with the S1P receptor 1 (S1P1) on lymphocytes, and LEC are the
main producers of S1P required for LN egress (Matloubian et al.,
2004; Pham et al., 2010). In some immune responses and inﬂam-
matory conditions, lymphocytes down-regulate S1P1 expression,
which blocks the egress of lymphocytes from the LN (Matloubian
et al., 2004). Down-regulation of S1P1 by internalization is one
of the major mechanisms of immune modulation by the drug
FTY720 (Brinkmann et al., 2004).
Lymphatic vessels play an important role in immune tolerance.
In an islet allograft model, Treg that are adoptively transferred
and migrate from the graft to LN via afferent lymphatics pre-
vent graft rejection. However, Treg which enter LN via HEV do
not (Zhang et al., 2009). During a cutaneous immune response,
Treg that move from skin to LN via afferent lymphatics are
more potent in immune suppressive capacity than LN-resident
Treg (Tomura et al., 2010). These ﬁndings suggest that migra-
tion through lymphatics may enhance the immunosuppressive
capacity of Treg. Alternatively, it is possible that Treg are primed
and activated in the peripheral tissues before migrating to LN.
The chemokines CCL19 and CCL21, which are secreted by LEC,
inhibit T cell proliferation (Ziegler et al., 2007). LN-resident LEC
mediate peripheral tolerance by expressing and presenting multi-
ple peripheral tissue antigens to CD8+ T cells and inducing their
deletion (Cohen et al., 2010). Inﬂamed, TNFα-stimulated LEC
reduce the expression of the co-stimulatory molecule CD86 by
DC, and suppress the ability of DC to induce T cell proliferation
via a Mac-1 (CD11b/CD18)/ICAM-1 (CD54)-dependent mecha-
nism (Podgrabinska et al., 2009). Thus, LEC can engage multiple
mechanisms to negatively regulate immune and inﬂammatory
responses.
Vascular endothelial growth factors (VEGF),especiallyVEGF-A
and VEGF-C, are involved in LEC proliferation and lymphangio-
genesis (Shibuya and Claesson-Welsh, 2006; Tammela and Alitalo,
2010). Among VEGF receptors (VEGFR), VEGFR-2 is expressed
both on blood vascular endothelium and lymphatic endothelium,
butVEGFR-3 is speciﬁc for lymphatic endothelium.VEGF-A pro-
motes lymphatic vessel formation via signaling through VEGFR-2
and the effect of VEGF-C is mediated by VEGFR-3. Chronic
inﬂammatory conditions are associated with lymphangiogenesis
in the draining LN,which enhances themigration of DC to LNand
DC–T cell interactions. VEGF-C is induced in response to proin-
ﬂammatory cytokines such as TNFα and IL-1β in several cells,
including macrophages and granulocytes (Tammela and Alitalo,
2010). In inﬂammatory conditions, entry of these immune cells
into the LN is markedly increased, which may be associated with
inﬂammatory lymphangiogenesis in LN. B cells in inﬂamed LN
produce VEGF-A and promote lymphangiogenesis (Angeli et al.,
2006). Chronically inﬂamed tissue also induces lymphangiogene-
sis in draining LN by producing VEGF-A, and this is independent
of B cells (Halin et al., 2007). On the other hand, T cells negatively
regulate LN lymphatic vessel formation through IFNγ (Kataru
et al., 2011). TGFβ also inhibits the proliferation and migration
of cultured human LEC as well as lymphangiogenesis (Oka et al.,
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2008). Together, these reports suggest a highly complex network
of tissue and LN interactions that regulate lymphangiogenesis.
In an islet allograft model, anti-VEGFR-3 mAb inhibits lym-
phangiogenesis and prolongs allograft survival, suggesting that
inhibition of lymphangiogenesis may prevent immunity and
inﬂammation (Yin et al., 2011). However, in an arthritis model
of TNF-transgenic mice and a chronic cutaneous inﬂamma-
tion model, anti-VEGFR-3 mAb increases inﬂammation in joints
and skin despite suppressing lymphangiogenesis (Guo et al.,
2009; Huggenberger et al., 2010). In contrast to anti-VEGFR-3
mAb,anti-VEGFR-2mAb suppresses both lymphangiogenesis and
inﬂammation in these two models. It is suggested that VEGFR-
2 and VEGFR-3 signaling pathways have different mechanisms
for reducing lymphangiogenesis, and that increased inﬂamma-
tion after speciﬁc blockade of VEGFR-3 is a result of improper
lymphatic drainagewith failure to resolve inﬂammatory inﬁltrates.
Lymph node lymphatics and HEV seem to be in synchrony.
B cell-derived VEGF-A promotes HEV expansion as well as lym-
phangiogenesis in LN (Shrestha et al., 2010). Both LN lymphatics
and HEV express LTβR, and lymphangiogenesis is accompanied
by upregulation of PNAd and LTβR by HEV, and is inhibited by
LTβRIg treatment (Liao and Ruddle, 2006). These ﬁndings suggest
that the two vascular systems engage in cross-talk through B cells
and LTβR (Table 1).
T CELLS
When T cells enter LN through HEV or lymphatics, they are
under the inﬂuence of chemokines secreted by LEC or vascular
endothelial cells such as CCL19 and CCL21, which can inhibit the
proliferation of T cells (Ziegler et al., 2007). Contact with endothe-
lial cells also can affect the immunologic properties of migrating
T cells. On the other hand, T cells can inﬂuence lymphatics and
negatively regulate LN lymphatic vessel formation through IFNγ
(Kataru et al., 2011).
T cell homing to LN plays a critical role in tolerance to alloanti-
gen because Treg develop and are required within the LN during
tolerance induction. If T cell homing to LN is inhibited by anti-
L-selectin (CD62L) mAb, cardiac allograft survival is prevented
despite a tolerogenic regimen of anti-CD40L mAb plus donor-
speciﬁc transfusion (Ochando et al., 2005). Only the CD62L+
subpopulation of Treg, which have the LN-homing adhesion mol-
ecule, are reported to protect from lethal GVHD in allogeneic bone
marrow transplantation model and delay adoptive transfer of dia-
betes (Szanya et al., 2002; Ermann et al., 2005). Follicular Treg are
present in LN, limit T follicular helper cell and germinal center
B cell numbers, and suppress germinal center reactions (Chung
et al., 2011; Linterman et al., 2011). In LN, Treg directly interact
with antigen-bearing DC by forming long-lasting conjugates to
inhibit T cell priming and activation by DC (Tang et al., 2006). In
the peripheral tissue, Treg inhibit DC migration to LN in a TGFβ
and IL-10 dependent fashion, which prevents priming of effector
T cells by DC in the LN (Zhang et al., 2009). These ﬁndings suggest
that LN are a major place where Treg exert their immune mod-
ulatory actions in various ways. Treg limit the access of immune
cells to LN and inhibit DC–T cell interactions in the LN for the
regulation of immune reactivity (Table 2).
PRIMARY LYMPHOID ORGANS
THYMUS
The thymus is a lymphoid organ that is critical for tolerance. It is
not only the site for eliminating self-reactive T cells through nega-
tive selection, but also for controlling self-reactive T cells through
CD4+Foxp3+ regulatory T cell (Treg) development. Delayed gen-
eration of Treg by thymectomy at day 3, but not day 7, results
in autoimmune disease development (Fontenot et al., 2005). Treg
development is observed only when the antigen is expressed in
the thymus (Jordan et al., 2001). Foxp3 is induced during very
early thymic developmental events before TCR rearrangement
Table 2 |Treg in lymphoid organs.
Primary lymphoid organ Thymus Treg development Involved cells:
Medullary epithelial cells expressing Aire, TSLP
Cortical DCs expressingTSLP
Recirculated immature DC
Involved molecules:
CD28, IL-2, TSLP, CD154, GITR, Stat5, TGFβ
Bone marrow Treg recruitment CXCR4/CXCL12 interaction
Treg role Providing immune-privileged sites for HSPC
Mobilized to peripheral tissue (i.e., tumor) via CCR4/CCL2 interaction
Secondary lymphoid organ Spleen Treg generation Involved cells:
Regulatory or immature DC from peripheral tissues
F4/80hiMac-1low macrophages in red pulp
LN Treg generation Involved cells:
DC migrated via afferent lymphatics
pDC migrated via HEV
Treg role Treg migrated from peripheral tissues more potent than LN-resident Tregs
Inhibition of T cell priming and activation byTreg–DC interaction
Inhibition of TFH cells/B cells/germinal center reaction by FTreg
Treg in peripheral tissues inhibit DCmigration to LN
Tertiary lymphoid organ Treg detected; role not certain
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(Pennington et al., 2006), suggesting a major role in determin-
ing T cell fate prior to or coincident with TCR engagement.
These reports all demonstrate the critical role of the thymus for
maintaining a protective suppressor cell population.
A number of observations show that Treg develop in the
medulla: expression of Aire within medullary thymic epithelial
cells (Aschenbrenner et al., 2007); the overwhelming majority of
Foxp3+ cells are found within the medulla (Fontenot et al., 2005);
and thymic stromal-derived lymphopoietin (TSLP) produced in
the medullary region of the human thymus is critical for Treg
development (Jiang et al., 2006). However, thymic DC also make
TSLP and these cells may be found in the cortex (Watanabe et al.,
2005); mice expressing MHC II only in the cortex are able to pro-
duce natural Treg (nTreg; Bensinger et al., 2001); and when thymic
migration from the cortex to the medulla was blocked by admin-
istering pertussis toxin (Liston et al., 2008), or through CCR7
deﬁciency (Kurobe et al., 2006), CD4+Foxp3+ Treg accumulate
within the cortex. Thus, both the thymic medulla and cortex par-
ticipate in nTreg development. In a study using TCR transgenic
models naturally devoid of Foxp3+ cells, it was observed that
de novo generation of Treg occurred intrathymically under non-
inﬂammatory conditions of antigen encounter and was essential
for robust tolerance induction (Zelenay et al., 2010).
Foxp3 expression does not commence until day 3 in neonates,
suggesting that only organized thymic architecture provides
proper co-stimulatory signals in the early thymus. CD28, IL-2R,
TSLP receptor, CD154, glucocorticoid-induced TNF receptor, and
Stat5 signals are all implicated in the development and lineage
commitment of thymus-derived nTreg (Bettini andVignali, 2010).
Although mice deﬁcient in TGFβ or TGFβ receptor II (TGFβRII)
have normal numbers of Treg in adult thymus, the numbers of
CD4+CD25+Foxp3+ thymocytes are greatly reduced in young
mice (Liu et al., 2008). Further, CD4+CD25+Foxp3+ thymocytes
are completely lost in mice lacking both TGFβRI and IL-2, indicat-
ing TGFβR signaling is involved in development and maintenance
of nTreg.
Various experimental models demonstrate that the thymus is
required for Treg development and consequent tolerance induc-
tion to alloantigens. In a rat model using immature myeloid
DC (imDC) primed with immune-dominant allopeptide in vitro,
DC re-circulate through the recipient thymus and result in
acquired graft-as-self-tolerance (Gopinathan et al., 2001; Oluwole
et al., 2001). CD4+CD25+Foxp3+ anti-donor Treg development
is dependent on the presence of the thymus for at least 2–3weeks
after imDC injection, and early thymectomy abolishes tolerance
(Oluwole et al., 2003). Trafﬁcking of donor alloantigen to the thy-
mus or inoculating the thymus directly with allopeptides induces
tolerance in large animal models, and thymectomy in recipients
prevents tolerance induction (Griesemer et al., 2010). Transplant-
ing porcine thymus tissue to mice leads to the development of
donor-speciﬁc tolerance in vitro (Lee et al., 1994), and indeﬁnite
donor-matched porcine skin graft survival (Zhao et al., 1996).
Transplanting vascularized porcine thymus tissue to baboons is
associated with donor-speciﬁc T cell unresponsiveness (Barth
et al., 2003), and the presence of thymic chimerism and donor
bone marrow engraftment correlate precisely with tolerance to
subsequent solid organ transplants (Horner et al., 2006). Overall,
these reports demonstrate that both T cell development in allo-
geneic or xenogeneic thymus can induce tolerance, and that DC
can trafﬁc to the thymus to present or cross-present alloantigens
for tolerance induction (Table 2).
BONE MARROW
Bone marrow is an essential part of the immature and
mature lymphocyte recirculation network, and it harbors mature
CD4+CD25+ Treg and serves as a Treg reservoir. Studies show
that CXCR4/CXCL12 signals play an important role in regulating
Treg trafﬁcking from bone marrow and in maintaining homeo-
static levels of Treg in the periphery. G-CSF treatment decreases
bone marrow CXCL12 expression, and results in Treg mobiliza-
tion from bone marrow into the periphery, and is consistent
with the low prevalence of acute GVHD and the improvement
in autoimmune diseases following G-CSF treatment (Zou et al.,
2004). In a ret transgenic mouse spontaneous melanoma model,
signiﬁcantly higher numbers of Treg are found in skin tumors
and metastatic LN at early stages of melanoma progression, com-
pared with more advanced stages, and inversely correlate with
Treg numbers in the bone marrow, suggesting trafﬁcking from
bone marrow to melanoma lesions. Elevated CCR4 expression is
observed on Treg, while higher production of its ligand CCL2 is
observed in tumor lesions, indicating CCR4/CCL2 signals play a
role in Treg mobilization (Kimpﬂer et al., 2009). Recent studies
show that the hematopoietic stem/progenitor cell (HSPC) niche
is immune-privileged in the bone marrow. Persistence and sur-
vival of both allogeneic and syngeneic HSPCs are observed after
30 days in non-irradiated recipient mice without immunosup-
pression. High-resolution in vivo imaging shows that HSPC are
colocalized with Treg and accumulate on the endosteal surface in
the calvarial and trabecular bone marrow, Treg actively partici-
pate in protection of allo-HSPC, and depleting FoxP3 regulatory
Treg cells results in allogeneic HSPC destruction (Fujisaki et al.,
2011).
The bone marrow is the primary site for B cell maturation.
Naive B cells then migrate to SLO, become plasmablasts upon
antigenic stimulation in antigen-activated T cell areas, secrete
low-afﬁnity antibody and eventually undergo apoptosis. Some
activated B cells enter into the long-lived memory compartment
as either memory B cells or long-lived plasma cells (PC). Long-
lived PC remain in either the LN or spleen, but most home to
and reside in the bone marrow. Long-lived PC in the marrow are
a major source of persistent donor-speciﬁc alloantibody (Stegall
et al., 2010). Long-lived PC are sensitive to proteasome inhibition
including bortezomib, but are not affected by rituximab, IVIG, or
thymoglobulin (Perry et al., 2009). Although PC also may exist
in SLO, the contribution of PC from areas other than the bone
marrow to alloantibody production is not clear. These documen-
tations all point to the bone marrow as a major site of immune
regulation for responses to alloantigens, and that real therapeutic
strategies must account for both Treg and PC in the bone marrow
(Table 3).
TERTIARY LYMPHOID ORGANS
Ectopic or tertiary lymphoid organs (TLO) are often induced
at sites of chronic infection or inﬂammation in peripheral
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Table 3 | Dendritic cell function in lymphoid organs.
Name Subset Phenotype Location Function
Activated or mature In the steady state or
tolerance
Lymphoid
organ-
resident
CD8+ CD11c+CD11b−
CD8+CD4− (also
CD103+CD207+
subset)
Spleen, LN and
thymus
Promote cytotoxic T cell responses CD8+ T cell tolerance
InduceTreg
T cell suppression by IOD
CD4+ T cell hyporesponsiveness (Mel-
lor et al., 2005; Dudziak et al., 2007;
Yamazaki et al., 2008; Dominguez and
Ardavin, 2010; Johnson et al., 2010;
Shortman and Heath, 2010)
CD4+ CD11c+CD11b+
CD8−CD4+
Spleen and LN Promote CD4+ T cell responses CD4+ T cell tolerance
Expansion ofTreg populations (Dudziak
et al., 2007; Dominguez and Ardavin,
2010; Shortman and Heath, 2010)
CD8−CD4− CD11c+CD8−CD4−
(CD11b+ and CD11b−
subsets)
Spleen and LN
Migratory CCR7+ LC(CD11c+
CD207+CD103−)
LN Transport the pathogen to the draining
LN and promoteT cell responses
Carry PTA from periphery into LN
CD8+ T cell tolerance
Induce Treg (Varol et al., 2009; Liu and
Nussenzweig, 2010)
CD103+(CD11c+
CD11b−CD103+)
Up-regulate homing receptors of
activatedT cells
CD103+CD11b+
(CD11c+CD11b+
CD103+)
CD11b+?
(CD11c+CD11b+
CD103−)
Not clear Not clear Not clear
Plasmacytoid CD11cmid
CD11b−CD8±
CD4+Gr-1+ (produce
type I IFNs)
Thymus, bone
marrow, and
secondary
lymphoid tissue
Anti-viral immunity InduceTregs
Alloimmune tolerance (Ochando et al.,
2006; Gilliet et al., 2008; Manches
et al., 2008; Swiecki andColonna, 2010)
Inﬂammatory
(TIP and
monocyte)
CD11c+CD11b+
Ly6C+ (produceTNF
and express iNOS)
Inﬂammatory
lesions
Induction of adaptive immunity Tezuka et al. (2007), Kool et al. (2008),
Dominguez and Ardavin (2010)
“?” indicates that these cells may express CD11b.
non-lymphoid organs. These tissues are architecturally similar to
SLO, with separate B and T cell areas, specialized populations of
DC, well-differentiated stromal cells, and HEV (Carragher et al.,
2008). It seems likely that similar signaling mechanisms that are
responsible for SLO ontogeny are involved in TLO formation
(Motallebzadeh et al., 2008). Like SLO, TLO are formed in a highly
regulated manner via production of homeostatic chemokines
(CXCL13 and CCL19/CCL21), and in response to signaling from
the heterotrimer lymphotoxin (LT) α1β2 acting on the LTβR on
stromal organizer cells (Drayton et al., 2006; van de Pavert and
Mebius, 2010). The expression of LTα, LTβ, and LIGHT all con-
tribute to the formation of TLO via signaling through TNFR1 and
LTβR (Lee et al., 2006). Although the organogenesis of LN clearly
requires LTi cells, whether LTi cells are required for formation
of TLO follicles is less clear (Carragher et al., 2008). Even with
deletion of the inhibitor of differentiation two gene, essential for
generation of CD3−CD4+ LTi cells and development of SLO,TLO
still form in the thyroid (Marinkovic et al., 2006).
Tertiary lymphoid organs have been described in a variety
of autoimmune diseases including gastritis, thyroiditis, and sys-
temic lupus erythematosus (Carragher et al., 2008). The formation
of TLO correlates with the development of diabetes, whereas
blocking their formation prevents the development of diabetes
(Wu et al., 2001; Lee et al., 2006; Penaranda et al., 2010). The
chronic phase of the immune response to an allograft is in many
ways similar to the responses that typify relapsing autoimmu-
nity. Autoimmune responses are characterized by immune envi-
ronments in which target antigens persist, and the inability to
eradicate alloantigens may provide a similar stimulus for for-
mation of TLO within the graft. After organ transplantation,
there are continuous low levels of dynamic interactions between
donor alloantigens and the recipient immune system, a situa-
tion similar to chronic inﬂammation. The positioning of lym-
phoid tissue within an inﬂamed allograft may thus result in more
aggressive effector lymphocyte responses that focuses on locally
presented alloantigens (Motallebzadeh et al., 2008). For example,
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TLO or PNAd+ HEV without organized lymphoid accumulation
are observed in murine heart transplants and in association with
chronic allograft rejection, but to a much lesser extent with acute
rejection (Baddoura et al., 2005). Germinal center-like structures
are present in chronically rejected human allografts (Motalle-
bzadeh et al., 2008). Some reports have shown that chronically
rejected allografts are simultaneously the target and the site of
production of alloantibodies (Smith et al., 2002; Kerjaschki et al.,
2004; Thaunat et al., 2005; Thaunat and Nicoletti, 2008). TLO
occur in rat donor allografts latently infectedwith cytomegalovirus
(CMV), and in part mediate ganciclovir-insensitive rejection by
providing a scaffold for immune activation (Orloff et al., 2011).
Similarly, pre-transplant human CMV infection is associated
with the acceleration of renal transplant vascular sclerosis and
chronic allograft rejection (Fitzgerald et al., 2004). TLO within
skin allografts are able to support effective alloresponses, lead-
ing to rejection, and development of a memory response (Nasr
et al., 2007). Thus, it appears that the generation of TLO is asso-
ciated with the chronic phase of destructive auto- or alloimmune
responses.
The ectopic accumulation of lymphoid cells has been consid-
ered to signify destructive inﬂammation that is accompanied by
tissue damage (Drayton et al., 2006).However, there are also exam-
ples inwhichTLOappear to contribute to local protective immune
responses. A high proportion of Treg are detected within the TLO
in gastric mucosa of mice with autoimmune gastritis and ath-
erosclerotic aortic media of apoE−/− mice (Katakai et al., 2006;
Grabner et al., 2009). T2-6AB transgenic mice, in which T cells
express a T cell receptor (TCR) speciﬁc for the H+/K+-ATPase
α subunit, spontaneously develop TLO, although autoimmune
responses are clearly limited. There is locally restricted T cell
activation and Th2 skewing of the self-reactive T cells, as well
as the accumulation of Treg in the target organ (Katakai et al.,
2006). Many tumors manipulate the immune environment to
escape immune surveillance. By secretion of CCL21, melanoma
tumor cells attract LTi cells, which are needed for the formation of
TLO-like structures within the tumor. Knockdown of endogenous
CCL21 expression in tumor cells induces antigen-speciﬁc immu-
nity and inhibits tumor growth. Hence, in melanoma tumors, the
TLO provide a tolerogenic environment by recruitment of regula-
tory leukocyte populations (Shields et al., 2010). Thus, depending
on the type of immune responses, generation of TLO at sites of
inﬂammation can lead to detrimental or pathological immune
responses, or may help resolve local inﬂammation or infection
(Motallebzadeh et al., 2008).
CONCLUSION AND PERSPECTIVES
While great progress has been made in understanding molecules,
signaling pathways, and cells important for alloimmunity, and
how to manipulate, interfere with, and suppress immune cell
activation, migration, and effectors functions to beneﬁt trans-
plantation, evidence has emerged that various lymphoid organs,
their anatomic structures, and particular microenvironments that
lymphocytes encounter or reside in during the course of the allore-
sponse are also critical in determining the ﬁnal outcome of graft
acceptance and transplant tolerance. The appropriate tissue archi-
tecturemay decide whether immune cells remain naïve, or become
activated, anergic, or deleted by affecting antigen presentation,
adhesion molecule expression, co-stimulatory signal activation,
cytokine and chemokine production, thus affect regulatory and
effector cell differentiation, trafﬁcking and effector activities. In
order to further overcome barriers to transplant tolerance, precise
models and investigations on the arrangement of cells and mole-
cules in lymphoid structures and anatomic pathways are required.
For example, how LTi/LTo interactions, LT signal cascades, stro-
mal cells, and speciﬁc microdomains affect immune responses
and transplant tolerance induction and maintenance will all be
productive areas for investigation.
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